Acceptability of Sexually Transmitted Infection Screening Among Women in Short-Term Substance Abuse Treatment

Lally, Michelle; Álvarez, Sara Olivares; MacNevin, Ryan; Cenedella, Carly; DiSpigno, Melissa; Harwell, Joseph I.; Pugatch, David; Flanigan, Timothy P.

doi:10.1097/00007435-200212000-00003

Cited by 19 publications

(17 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Persons who use substances participate in behaviors that place them and others at substantial risk for these infections (Bachmann et al, 2000;Battjes et al, 1995;Belongia et al, 1997;Booth et al, 1993;Broers et al, 1998;Chiasson et al, 1991;Fortenberry et al, 1999;Francis, 2003;Garfein et al, 1998;Lorvich et al, 2001;Plitt et al, 2005;Poulin et al, 1999;Thomas et al, 1995;Zylberberg & Pol, 1996). Substance abuse treatment or various services provided in the mix of services in substance abuse treatments have been demonstrated to be important tools in developing effective responses to reduce the transmission of these infections (Brown, Chu, Nemoto, Ajuluchukwu, & Primm, 1989;Cooper, 1989;Hartel & Schoenbaum, 1998;Hubbard, Marsden, Cavanaugh, Rachal, & Ginsburg, 1988;Lally et al, 2002Lally et al, , 2005Metzger, Navaline, & Woody, 1998;Sorensen & Copeland, 2000). Determining that relevant services exist represents an important prerequisite to assessing effectiveness.…”

Section: Discussionmentioning

confidence: 99%

“…Prior reports were based either on investigations of infection-related services in a single substance abuse treatment program or on a group of local or regional programs (Brown et al, 1989;Hartel & Schoenbaum, 1998;Lally et al, 2002Lally et al, , 2005Sylvestre, 2002). Strauss, Falkin, Vassilev, Des Jarlais, and Astone (2002) reported the results of a survey of program directors from a randomized sample of substance abuse treatment programs derived from a nationwide list maintained by SAMHSA.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network

Brown¹,

Kritz²,

Goldsmith³

et al. 2006

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

Illicit drug users sustain the epidemics of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hepatitis C (HCV), and sexually transmitted infections (STIs). Substance abuse treatment programs present a major intervention point in stemming these epidemics. As a part of the "Infections and Substance Abuse" study, established by the National Drug Abuse Treatment Clinical Trials Network, sponsored by National Institute on Drug Abuse, three surveys were developed; for treatment program administrators, for clinicians, and for state and District of Columbia health and substance abuse department administrators, capturing service availability, government mandates, funding, and other key elements related to the three infection groups. Treatment programs varied in corporate structure, source of revenue, patient census, and medical and non-medical staffing; medical services, counseling services, and staff education targeted HIV/ AIDS more often than HCV or STIs. The results from this study have the potential to generate hypotheses for further health services research to inform public policy.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network

Brown¹,

Kritz²,

Goldsmith³

et al. 2006

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

show abstract

“…20 The prevalence of chlamydia and gonorrhea reported in this cohort was similar to those reported from other young drug-using populations. 2,[21][22][23][24] In a study of young IDUs by Latka et al in the CIDUS-II multicenter study, the prevalence of chlamydia was 5.2% and did not differ by gender. Gonorrhea prevalence was 2% among women and 0.2% among men.…”

Section: Discussionmentioning

confidence: 99%

Prevalence and Correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and Bacterial Vaginosis Among a Cohort of Young Injection Drug Users in Baltimore, Maryland

Plitt

Garfein²,

Gaydos³

et al. 2005

Sexually Transmitted Diseases

View full text Add to dashboard Cite

show abstract

“…Several studies tested for both gonorrhea and chlamydia in drug users (Bachmann et al, 2000;Friedman et al, 2003;Gunn et al, 2005;Hwang et al, 2000;Lally et al, 2002;Latka et al, 2001;Liebschutz et al, 2003;Ross et al, 2002). For gonorrhea, a prevalence rate ranging from 1% to 3% was reported in those studies.…”

Section: Stds Among Drug Usersmentioning

confidence: 99%

Behavior Change and Health-Related Interventions for Heterosexual Risk Reduction Among Drug Users

Semaan

Jarlais

Malow

2006

Substance Use & Misuse

View full text Add to dashboard Cite

Prevention of heterosexual transmission of HIV between and from drug users is important for controlling the local and global HIV heterosexual epidemic. Sex risk reduction interventions and health-related interventions are important for reducing the sex risk behaviors of drug users. Sex risk reduction interventions address individual-level, peer-level, and structural-level determinants of risk reduction. Health-related interventions include HIV counseling and testing, prevention and treatment of sexually transmitted diseases, and delivery of highly active antiretroviral therapy. It is important to adapt effective interventions implemented in resource-rich countries to the realities of the resourceconstrained settings and to address relevant contextual factors.RESUMEN-Il est important de prévenir la transmission hétérosexuelle du VIH à partir des usagers de drogue pour contrôler l'épidémie hétérosexuelle locale et mondiale de VIH. Des interventions ciblant à la fois la réduction de risque sexuel et la santé des usagers de drogue sont nécessaires. Les interventions de réduction de risque sexuel prennent en compte le niveau individuel, le niveau des pairs et celui des déterminants structurels de la réduction des risques. Les interventions visant l'amélioration de la santé comprennent le conseil et le dépistage du VIH, la prévention et le traitement des infections sexuellement transmissibles et la prescription d'antirétroviraux. Il est important d'adapter les interventions efficaces mises en place dans les pays riches aux réalités des contextes de pays à ressources limitées et de tenir compte des facteurs contextuels pertinents. Keywords global research; HIV; injection drug use; research interventions; sexual risk HIV Infection and Injection Drug UsersInjection drug use continues to complicate the control of the global HIV epidemic (UNAIDS, 2004). In 2003, 136 countries reported injecting drug use and 93 countries reported HIV infection among injection drug users (IDUs) (World Health Organization, 2003). IDUs are at risk for infection with HIV through both multiperson use ("sharing") of drug injection equipment and through unsafe sex behaviors (Aceijas et al., 2004). Although the scope and effectiveness of interventions aimed at reducing HIV infection through drug injection equipment has been well documented in the literature (Des Jarlais et al., 2005;Quan et This review describes sex risk reduction interventions with drug users and their effectiveness in reducing sexual risk behaviors of IDUs and other drug users. We highlight the needs and opportunities for these interventions, discuss the generalizability of the results to resourceconstrained settings, and outline the implications for global research efforts and public health practice. Although our literature review is not comprehensive, it highlights many areas that affect sexual transmission of HIV to and from drug users in both resource-rich and resourceconstrained settings. Efforts to reduce substance abuse and HIV risk associated with injection behav...

show abstract

Acceptability of Sexually Transmitted Infection Screening Among Women in Short-Term Substance Abuse Treatment

Abstract: STI screening is highly acceptable among women in substance abuse treatment centers. Substance users are at high risk for STIs and may not otherwise receive medical care.

Cited by 19 publications

References 21 publications

Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network

Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network

Prevalence and Correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and Bacterial Vaginosis Among a Cohort of Young Injection Drug Users in Baltimore, Maryland

Behavior Change and Health-Related Interventions for Heterosexual Risk Reduction Among Drug Users

Contact Info

Product

Resources

About